Adkins et al., 2005 - Google Patents
A proteomic study of the HUPO Plasma Proteome Project's pilot samples using an accurate mass and time tag strategyAdkins et al., 2005
View PDF- Document ID
- 7257848174548596674
- Author
- Adkins J
- Monroe M
- Auberry K
- Shen Y
- Jacobs J
- Camp D
- Vitzthum F
- Rodland K
- Zangar R
- Smith R
- Pounds J
- Publication year
- Publication venue
- Proteomics
External Links
Snippet
Abstract Characterization of the human blood plasma proteome is critical to the discovery of routinely useful clinical biomarkers. We used an accurate mass and time (AMT) tag strategy with high‐resolution mass accuracy cLC‐FT‐ICR MS to perform a global proteomic analysis …
- 210000002381 Plasma 0 title abstract description 72
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6827—Total protein determination, e.g. albumin in urine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2458/00—Labels used in chemical analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Adkins et al. | A proteomic study of the HUPO Plasma Proteome Project's pilot samples using an accurate mass and time tag strategy | |
Adkins et al. | Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry | |
Larsen et al. | Analysis of posttranslational modifications of proteins by tandem mass spectrometry: Mass Spectrometry For Proteomics Analysis | |
Li et al. | Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures | |
Roe et al. | Gel‐free mass spectrometry‐based high throughput proteomics: Tools for studying biological response of proteins and proteomes | |
EP1472539B1 (en) | Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry | |
Farley et al. | Identification and quantification of protein posttranslational modifications | |
Cagney et al. | In silico proteome analysis to facilitate proteomics experiments using mass spectrometry | |
Palmblad et al. | Mass spectrometry in clinical proteomics–from the present to the future | |
BRPI0711967A2 (en) | mass spectrometry biomarker assay | |
US20060004525A1 (en) | System and method of determining proteomic differences | |
Pasella et al. | Pre-analytical stability of the plasma proteomes based on the storage temperature | |
Florentinus et al. | Identification and quantification of peptides and proteins secreted from prostate epithelial cells by unbiased liquid chromatography tandem mass spectrometry using goodness of fit and analysis of variance | |
Poetz et al. | Proteome wide screening using peptide affinity capture | |
Mohammed et al. | Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer | |
Qian et al. | High-throughput proteomics using Fourier transform ion cyclotron resonance mass spectrometry | |
Lee et al. | Application of a peptide‐based PF2D platform for quantitative proteomics in disease biomarker discovery | |
Lee et al. | Proteomic analysis of the effect of storage temperature on human serum | |
Merkley et al. | A proteomics tutorial | |
Salzano et al. | Mass spectrometry for protein identification and the study of post translational modifications | |
Palmblad et al. | A novel mass spectrometry cluster for high-throughput quantitative proteomics | |
WO2005057208A1 (en) | Methods of identifying peptides and proteins | |
Mesmin et al. | Complexity reduction of clinical samples for routine mass spectrometric analysis | |
Spengler | Accurate mass as a bioinformatic parameter in data-to-knowledge conversion: Fourier transform ion cyclotron resonance mass spectrometry for peptide de novo sequencing | |
Linke et al. | Identification and relative quantification of phosphopeptides by a combination of multi‐protease digestion and isobaric labeling |